Minerva Neurosciences Net Income

Minerva Neurosciences (NERV) currently reports a net income of $-2.9T as of June 2026. That compares with $23T in the prior-year period — down 112.7% year over year. That is below the Healthcare sector average of $16B. Use the charts on this page to explore Minerva Neurosciences's net income history and peer comparisons.

Minerva Neurosciences's net income decreased from $23T to $-2.9T — a 112.7% year-over-year decrease (period ending June 2026). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.

Minerva Neurosciences's net income of $-2.9T is lower than the Healthcare sector average of $16B. That is roughly 18040.5% below the sector mean. A reading lower peers can reflect different growth expectations, capital structure, or profitability — so it is worth checking the peer comparison chart before drawing conclusions.

Minerva Neurosciences reported $-2.9T in net income as of June 2026. That compares with $23T in the prior-year period — down 112.7% year over year. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.

Start with the current net income of $-2.9T, then check the historical chart for trend and the peer comparison chart for relative positioning. The Healthcare average is $16B. From there, open related valuation or income-statement pages for Minerva Neurosciences, and consider following NERV for alerts when major investors trade the stock.